Annual CFF
$86.17 M
+$86.24 M+118136.99%
December 31, 2023
Summary
- As of February 20, 2025, SGMT annual cash flow from financing activities is $86.17 million, with the most recent change of +$86.24 million (+118136.99%) on December 31, 2023.
- During the last 3 years, SGMT annual CFF has risen by +$17.28 million (+25.09%).
- SGMT annual CFF is now at all-time high.
Performance
SGMT Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$0.00
+$27.00 K+100.00%
September 30, 2024
Summary
- As of February 20, 2025, SGMT quarterly cash flow from financing activities is $0.00, with the most recent change of +$27.00 thousand (+100.00%) on September 30, 2024.
- Over the past year, SGMT quarterly CFF has stayed the same.
- SGMT quarterly CFF is now -100.00% below its all-time high of $104.85 million, reached on March 31, 2024.
Performance
SGMT Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$104.82 M
-$87.21 M-45.42%
September 30, 2024
Summary
- As of February 20, 2025, SGMT TTM cash flow from financing activities is $104.82 million, with the most recent change of -$87.21 million (-45.42%) on September 30, 2024.
- Over the past year, SGMT TTM CFF has increased by +$18.65 million (+21.65%).
- SGMT TTM CFF is now -45.42% below its all-time high of $192.03 million, reached on June 30, 2024.
Performance
SGMT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
SGMT Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10000.0% | 0.0% | +21.6% |
| 3 y3 years | +25.1% | +100.0% | +10000.0% |
| 5 y5 years | +366.1% | +100.0% | +10000.0% |
SGMT Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | -100.0% | +100.0% | -45.4% | +9620.4% |
| 5 y | 5-year | at high | >+9999.0% | -100.0% | +100.0% | -45.4% | +9620.4% |
| alltime | all time | at high | >+9999.0% | -100.0% | +100.0% | -45.4% | +9620.4% |
Sagimet Biosciences Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(-100.0%) | $104.82 M(-45.4%) |
| Jun 2024 | - | -$27.00 K(-100.0%) | $192.03 M(+0.5%) |
| Mar 2024 | - | $104.85 M(>+9900.0%) | $191.15 M(+121.8%) |
| Dec 2023 | $86.17 M(<-9900.0%) | $0.00(-100.0%) | $86.17 M(+0.1%) |
| Sep 2023 | - | $87.21 M(-9683.8%) | $86.11 M(-7921.3%) |
| Jun 2023 | - | -$910.00 K(+569.1%) | -$1.10 M(+398.2%) |
| Mar 2023 | - | -$136.00 K(+147.3%) | -$221.00 K(+202.7%) |
| Dec 2022 | -$73.00 K | -$55.00 K(<-9900.0%) | -$73.00 K(+305.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $0.00(-100.0%) | -$18.00 K(0.0%) |
| Jun 2022 | - | -$30.00 K(-350.0%) | -$18.00 K(-250.0%) |
| Mar 2022 | - | $12.00 K(-99.9%) | $12.00 K(-99.9%) |
| Dec 2021 | $9.74 M(-85.9%) | - | - |
| Mar 2021 | - | $11.14 M(>+9900.0%) | $11.14 M(>+9900.0%) |
| Dec 2020 | $68.89 M(+272.7%) | - | - |
| Mar 2020 | - | $0.00 | $0.00 |
| Dec 2019 | $18.48 M | - | - |
FAQ
- What is Sagimet Biosciences annual cash flow from financing activities?
- What is the all time high annual CFF for Sagimet Biosciences?
- What is Sagimet Biosciences annual CFF year-on-year change?
- What is Sagimet Biosciences quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Sagimet Biosciences?
- What is Sagimet Biosciences quarterly CFF year-on-year change?
- What is Sagimet Biosciences TTM cash flow from financing activities?
- What is the all time high TTM CFF for Sagimet Biosciences?
- What is Sagimet Biosciences TTM CFF year-on-year change?
What is Sagimet Biosciences annual cash flow from financing activities?
The current annual CFF of SGMT is $86.17 M
What is the all time high annual CFF for Sagimet Biosciences?
Sagimet Biosciences all-time high annual cash flow from financing activities is $86.17 M
What is Sagimet Biosciences annual CFF year-on-year change?
Over the past year, SGMT annual cash flow from financing activities has changed by +$86.24 M (+118136.99%)
What is Sagimet Biosciences quarterly cash flow from financing activities?
The current quarterly CFF of SGMT is $0.00
What is the all time high quarterly CFF for Sagimet Biosciences?
Sagimet Biosciences all-time high quarterly cash flow from financing activities is $104.85 M
What is Sagimet Biosciences quarterly CFF year-on-year change?
Over the past year, SGMT quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is Sagimet Biosciences TTM cash flow from financing activities?
The current TTM CFF of SGMT is $104.82 M
What is the all time high TTM CFF for Sagimet Biosciences?
Sagimet Biosciences all-time high TTM cash flow from financing activities is $192.03 M
What is Sagimet Biosciences TTM CFF year-on-year change?
Over the past year, SGMT TTM cash flow from financing activities has changed by +$18.65 M (+21.65%)